Exotoxin produced by Pseudomonas aeruginosa
For the Streptococcal superantigen SpeA, also referred to as
exotoxin A, see
Erythrogenic toxin.
The Pseudomonas exotoxin (or exotoxin A) is an exotoxin produced by Pseudomonas aeruginosa.[1] Vibrio cholerae produces a similar protein called the Cholix toxin (Q5EK40).[2]
It inhibits elongation factor-2. It does so by ADP-ribosylation of EF2 using NAD+. This then causes the elongation of polypeptides to cease. This mechanism is similar to that of diphtheria toxin.[3]
It has been investigated as a treatment for hepatitis B[4] and cancer.[5]
- ^ Yates SP, Taylor PL, Jørgensen R, Ferraris D, Zhang J, Andersen GR, Merrill AR (February 2005). "Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa". The Biochemical Journal. 385 (Pt 3): 667–75. doi:10.1042/BJ20041480. PMC 1134741. PMID 15458385.
- ^ Jørgensen R, Purdy AE, Fieldhouse RJ, Kimber MS, Bartlett DH, Merrill AR (April 2008). "Cholix toxin, a novel ADP-ribosylating factor from Vibrio cholerae". The Journal of Biological Chemistry. 283 (16): 10671–8. doi:10.1074/jbc.M710008200. PMID 18276581.
- ^ Yates SP, Merrill AR (May 2004). "Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A". The Biochemical Journal. 379 (Pt 3): 563–72. doi:10.1042/BJ20031731. PMC 1224111. PMID 14733615.
- ^ Hafkemeyer P, Brinkmann U, Brinkmann E, Pastan I, Blum HE, Baumert TF (May 2008). "Pseudomonas exotoxin antisense RNA selectively kills hepatitis B virus infected cells". World Journal of Gastroenterology. 14 (18): 2810–7. doi:10.3748/wjg.14.2810. PMC 2710720. PMID 18473403.
- ^ Stuckey DW, Hingtgen SD, Karakas N, Rich BE, Shah K (February 2015). "Engineering toxin-resistant therapeutic stem cells to treat brain tumors". Stem Cells. 33 (2): 589–600. doi:10.1002/stem.1874. PMC 4305025. PMID 25346520.